Monthly Archives: October 2009

If Not This, Then What? If Not Now, Then When?

Sponsored Guest Blog by: Craig Nestel Business Solutions Manager SAS Global Healthcare and Life Sciences Practice I’ve been an avid runner for a long time. A while back, I had an injury that just wasn’t responding to any of the methods that I had used for years. And yet, I was reluctant to change anything. […]
Posted in Guest Blog, Strategy | Tagged , , , , , , , | 1 Comment

Connect with a Click of the Mouse

Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference. More than 250 people were in attendance for the two-day event, which included pharma marketers, brand managers, and patient education specialists who […]
Posted in E-Media, Events | Tagged , , , , , , , , , | Leave a comment

Europe: Go Easy on Your Pharma Lobbyists

European pharmaceutical executives are sometimes heard to complain that their public affairs departments are not doing a good job for them, and that their industry associations are a waste of time and money. A report published in Brussels earlier this month suggests that this judgment may be excessively harsh. Lobbyists for healthcare and pharmaceuticals score […]
Posted in Europe, Regulatory | Tagged , , , , | Leave a comment

AstraZeneca, BMS Announce Layoffs and Buyouts

AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force. “AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they […]
Posted in Strategy | Tagged , , , , , , , , | 1 Comment

IMS Health is Looking for Suitors

IMS Health, on Tuesday, confirmed that its board of directors formed a committee to explore strategic alternatives, or as the Associated Press reported, “advanced discussions to sell the company.” “There can be no assurance that the exploration of strategic alternatives will result in a transaction,” IMS stated in a release. “[IMS Health] stated that it […]
Posted in News, Strategy | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta